Author + information
- Alexander C. Fanaroff,
- Lisa Kaltenbach,
- Eric Peterson,
- Gregg Fonarow,
- Connie Hess,
- David Cohen and
- Tracy Wang
Background: Angina following myocardial infarction (MI) has important implications for quality of life and healthcare utilization. However, longitudinal patterns of post-MI angina and antianginal management have not been described.
Methods: TRANSLATE-ACS was a longitudinal observational study of MI patients treated with percutaneous coronary intervention (PCI) at 233 US hospitals from 2010-2012. We described patterns of self-reported angina frequency and non-beta blocker antianginal medication use through 1 year post-discharge.
Results: Of 10,870 PCI-treated MI patients, 3190 (31%) reported angina symptoms at 6 weeks post-discharge; of these 658 (21%) had daily/weekly angina and 2532 (79%) had at least monthly angina. Among patients with angina at 6 weeks, 743 (24%) reported using non-beta blocker antianginal medications (Figure shows use by time and medication type) and 381 patients (12%) underwent unplanned coronary revascularization in the 1 year post-MI. Only 106 (28%) patients were taking an antianginal medication at the time of revascularization. A third (n=1056) of patients with angina at 6 weeks had persistent angina symptoms 1 year post-MI; of these, only 31% reported taking non-beta blocker antianginal medications in the last year.
Conclusions: Angina is present in a third of PCI-treated MI patients as early as 6 weeks after discharge, and many of these patients have persistent angina at 1 year. Non-beta blocker antianginal medications are infrequently used in these patients.
Room 150 A
Sunday, March 19, 2017, 8:12 a.m.-8:22 a.m.
Session Title: Highlighted Original Research: Acute and Stable Ischemic Heart Disease and the Year in Review
Abstract Category: 3. Acute and Stable Ischemic Heart Disease: Therapy
Presentation Number: 907-04
- 2017 American College of Cardiology Foundation